Current Approved Therapeutic Protocols for COVID-19 | ICTR

Last updated May 27, 2020 A Randomized Placebo-Controlled Safety and Dose-Finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients with Life

Read the full article here

Related Articles